EMPHASYS™ Acetabular Solutions

Joint dislocation is still a significant challenge in hip replacement. EMPHASYS Acetabular Solutions provides an enhanced ability to treat patients who are at high risk of dislocation1 via an acetabular system that is designed with uncompromising stability in mind.2

EMPHASYS™ Acetabular Solutions is designed with uncompromising stability in mind through purposeful component enhancements and intuitive instrumentation to meet today’s surgical challenges.2

EMPHASYS™ Acetabular Solutions is designed to provide:

  • Uncompromising Stability1
  • Enhanced Operational Efficiencies3
  • One Comprehensive System2,4

DePuy Synthes Further Reimagines Knee Restoration with the Addition of Two New Innovations to the ATTUNE™ Knee Portfolio

ATTUNE™ Cementless Fixed Bearing Knee with AFFIXIUM™ 3DP Technology and the ATTUNE Medial Stabilized Knee System are designed for more natural knee function

WARSAW, IN, March 16, 2022 – Today, Johnson & Johnson MedTech* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, is adding two new innovations to its kinematically advanced and proveni,ii,iii,iv,v,vi ATTUNE™ Knee portfolio: the ATTUNE™ Cementless Fixed Bearing Knee with AFFIXIUM™ 3DP Technology and the ATTUNE™ Medial Stabilized Knee System.

Continue reading

INHANCE™ Shoulder System from DePuy Synthes Receives FDA 510(k) Clearance for Use in Reverse Total Shoulder Arthroplasty

The INHANCE Shoulder System is a first-to-market, fully convertible shoulder arthroplasty system that provides an efficient and intuitive plan to help simplify the surgeon and operating room (OR) staff’s existing workflow. 

Designed for hospitals as well as outpatient and ASC settings where economic value and operational efficiency are critical considerations.

 

Warsaw, IN – May 16, 2022 – Today, Johnson & Johnson MedTech* announced that the INHANCE™ Shoulder System from DePuy Synthes, the Orthopaedics Company of Johnson & Johnson,** has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use in reverse total shoulder arthroplasty procedures. This clearance is in addition to the system’s already cleared use in anatomic shoulder arthroplasty and provides surgeons with interoperative flexibility.

Continue reading